Additionally, more studies on the value of cytoplasmic HER2 expression in CRC must be done as if cytoplasmic HER2 has a pathophysiological role in CRC, intracellular HER2-targeting compounds might be a new treatment choice for these patients. Here, ERBB2 is linked to colorectal carcinoma.